D.E. Shaw & Co’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.7M | Sell |
|
|||||
|
2025
Q2 | $2.13M | Sell |
|
|||||
|
2025
Q1 | $2.12M | Sell |
|
|||||
|
2024
Q4 | $2.42M | Sell |
|
|||||
|
2024
Q3 | $5.19M | Sell |
|
|||||
|
2024
Q2 | $6.93M | Sell |
|
|||||
|
2024
Q1 | $9.96M | Sell |
|
|||||
|
2023
Q4 | $6.01M | Buy |
|
|||||
|
2023
Q3 | $4.03M | Buy |
|
|||||
|
2023
Q2 | $1.12M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $221K | Hold |
|
|||||
|
2022
Q3 | $246K | Hold |
|
|||||
|
2022
Q2 | $224K | Sell |
|
|||||
|
2022
Q1 | $435K | Sell |
|
|||||
|
2021
Q4 | $1.83M | Buy |
|
|||||
|
2021
Q3 | $587K | Sell |
|
|||||
|
2021
Q2 | $1.09M | Sell |
|
|||||
|
2021
Q1 | $2.03M | Buy |
|
|||||
|
2020
Q4 | $935K | Sell |
|
|||||
|
2020
Q3 | $1.11M | Buy |
|
|||||
|
2020
Q2 | $744K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $498K | Sell |
|
|||||
|
2019
Q3 | $679K | Buy |
|
|||||
|
2019
Q2 | $226K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $372K | Sell |
|
|||||
|
2018
Q3 | $551K | Sell |
|
|||||
|
2018
Q2 | $3.74M | Buy |
|
|||||
|
2018
Q1 | $2.45M | Buy |
|
|||||
|
2017
Q4 | $785K | Sell |
|
|||||
|
2017
Q3 | $919K | Sell |
|
|||||
|
2017
Q2 | $1.39M | Buy |
|
|||||
|
2017
Q1 | $487K | Sell |
|
|||||
|
2016
Q4 | $1.04M | Sell |
|
|||||
|
2016
Q3 | $2.32M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $224K | Buy |
|